Pharmaceuticals - San Francisco, California, United States
Epiphany is a biopharmaceutical company focusing on the development of a novel cancer drug to inhibit function of EGF receptors through the endocitosis of the same. The later is achieved targeting a yet atypical for the industry standards regulatory pathway.
Google AdSense
Google Cloud Hosting
Mobile Friendly